BlackRock Fund Advisors’s Tandem Diabetes Care TNDM Stock Holding History

BlackRock Fund Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.3M	Buy	60,483 +9,578	+19%	+$368K	﹤0.01%	3210
2016 Q3	$3.9M	Buy	50,905 +3,172	+7%	+$231K	﹤0.01%	2967
2016 Q2	$3.6M	Buy	47,733 +1,912	+4%	+$154K	﹤0.01%	2991
2016 Q1	$3.99M	Sell	45,821 -1,910	-4%	-$167K	﹤0.01%	2855
2015 Q4	$5.64M	Buy	47,731 +766	+2%	+$76K	﹤0.01%	2778
2015 Q3	$4.14M	Buy	46,965 +870	+2%	+$101K	﹤0.01%	2898
2015 Q2	$5M	Buy	46,095 +16,379	+55%	+$2.04M	﹤0.01%	2923
2015 Q1	$3.75M	Buy	29,716 +5,699	+24%	+$741K	﹤0.01%	2970
2014 Q4	$3.05M	Buy	24,017 +3,474	+17%	+$482K	﹤0.01%	3075
2014 Q3	$2.76M	Sell	20,543 -900	-4%	-$126K	﹤0.01%	3056
2014 Q2	$3.49M	Sell	21,443 -4,448	-17%	-$757K	﹤0.01%	3021
2014 Q1	$5.72M	Buy	25,891 +611	+2%	+$156K	﹤0.01%	2740
2013 Q4	$6.51M	Buy	+25,280	New	+$5.78M	﹤0.01%	2647

Other funds holding TNDM

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Fund Advisors's TNDM Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Tandem Diabetes Care (TNDM) stake by 19% in Q4 2016, buying an estimated $368K and bringing the position to 60,483 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3210.

BlackRock Fund Advisors first reported a position in TNDM in Q4 2013 and has held it in 13 quarters since. The position peaked at $6.51M in Q4 2013. 75 funds tracked by Wall St. Rank hold TNDM as of Q4 2016.

BlackRock Fund Advisors held 60,483 shares of Tandem Diabetes Care worth $1.3M as of Q4 2016.
BlackRock Fund Advisors bought 9,578 Tandem Diabetes Care shares in Q4 2016, an estimated $368K.
Tandem Diabetes Care made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3210 holding.
BlackRock Fund Advisors first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 13 quarters since.
BlackRock Fund Advisors's Tandem Diabetes Care position peaked at $6.51M in Q4 2013.
75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.